Login / Signup

Efficacy and Safety of Switching Patients Inadequately Controlled on Basal Insulin to Insulin Glargine 300 U/mL: The TRANSITION 2 Study.

Pierre GourdyAmar BahloulZahra BoultifDidier GouetBruno Guerci
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)
EudraCT number 2015-002416-33.
Keyphrases
  • type diabetes
  • end stage renal disease
  • glycemic control
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • adipose tissue